Viewing Study NCT01194960


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-27 @ 11:58 PM
Study NCT ID: NCT01194960
Status: TERMINATED
Last Update Posted: 2020-10-19
First Post: 2010-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Sponsor: Oxford BioMedica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module